🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the present study is to investigate the influence ...
Status
Completed
Location
PRA Hungary Ltd., Phase I. Clinical Pharmacology Unit
Start Date
2013-02-04
Trial ID
NCT01772563
Treatments Being Tested
The purpose of this study is to assess how well laroprovstat and ezetimibe ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2026-06-10
Trial ID
NCT07622433
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of 7MW3711 in c...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2026-02-11
Trial ID
NCT07466160
Treatments Being Tested
The SchistoSAM study is an open label, two-arm, individually-randomized con...
Status
Completed
Location
Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF)
Start Date
2019-10-14
Trial ID
NCT03893097
Treatments Being Tested
This is an open-label, multicenter, Phase Ib study to determine the maximum...
Status
Completed
Location
Rigshospitalet
Start Date
2021-07-14
Trial ID
NCT04826003
Treatments Being Tested
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
This is a prospective, monocenter, single arm, phase II trial in 33 patient...
Status
Completed
Location
Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis
Start Date
2016-09
Trial ID
NCT03048474
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of a fixed...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-09
Trial ID
NCT00382096
Treatments Being Tested
Consistent with previous literature, the investigators postulate that a leu...
Status
Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2026-01-01
Trial ID
NCT07537361
Treatments Being Tested